BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30537980)

  • 1. Targeted radiotherapy of pigmented melanoma with
    Xu X; Yuan L; Gai Y; Liu Q; Yin L; Jiang Y; Wang Y; Zhang Y; Lan X
    J Exp Clin Cancer Res; 2018 Dec; 37(1):306. PubMed ID: 30537980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of ¹²³/¹³¹I-Iochlonicotinamide as a novel SPECT probe for malignant melanoma.
    Chang CC; Chang CH; Shen CC; Chen CL; Liu RS; Lin MH; Wang HE
    Bioorg Med Chem; 2015 May; 23(9):2261-9. PubMed ID: 25800432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Radioiodinated Fluoronicotinamide/Fluoropicolinamide-Benzamide Derivatives as Theranostic Agents for Melanoma.
    Chen CC; Chen YY; Lo YH; Lin MH; Chang CH; Chen CL; Wang HE; Wu CY
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32916962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and biologic evaluation of a novel radioiodinated benzylpiperazine, 123I-MEL037, for malignant melanoma.
    Pham TQ; Berghofer P; Liu X; Greguric I; Dikic B; Ballantyne P; Mattner F; Nguyen V; Loc'h C; Katsifis A
    J Nucl Med; 2007 Aug; 48(8):1348-56. PubMed ID: 17631542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and characterization of a novel radioiodinated phenylacetamide and its homolog as theranostic agents for malignant melanoma.
    Chang CC; Chang CH; Shen CC; Chen CL; Liu RS; Lin MH; Wang HE
    Eur J Pharm Sci; 2016 Jan; 81():201-9. PubMed ID: 26517961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theranostic Approach for Metastatic Pigmented Melanoma Using ICF15002, a Multimodal Radiotracer for Both PET Imaging and Targeted Radionuclide Therapy.
    Rbah-Vidal L; Vidal A; Billaud EM; Besse S; Ranchon-Cole I; Mishellany F; Perrot Y; Maigne L; Moins N; Guerquin-Kern JL; Degoul F; Chezal JM; Auzeloux P; Miot-Noirault E
    Neoplasia; 2017 Jan; 19(1):17-27. PubMed ID: 27987437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of an 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma.
    Joyal JL; Barrett JA; Marquis JC; Chen J; Hillier SM; Maresca KP; Boyd M; Gage K; Nimmagadda S; Kronauge JF; Friebe M; Dinkelborg L; Stubbs JB; Stabin MG; Mairs R; Pomper MG; Babich JW
    Cancer Res; 2010 May; 70(10):4045-53. PubMed ID: 20442292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Preclinical Evaluation of
    Xu X; Yuan L; Yin L; Jiang Y; Gai Y; Liu Q; Wang Y; Zhang Y; Lan X
    Mol Pharm; 2017 Nov; 14(11):3896-3905. PubMed ID: 29037039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted radionuclide therapy of melanoma: anti-tumoural efficacy studies of a new 131I labelled potential agent.
    Bonnet-Duquennoy M; Papon J; Mishellany F; Labarre P; Guerquin-Kern JL; Wu TD; Gardette M; Maublant J; Penault-Llorca F; Miot-Noirault E; Cayre A; Madelmont JC; Chezal JM; Moins N
    Int J Cancer; 2009 Aug; 125(3):708-16. PubMed ID: 19437532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of novel radioiodinated nicotinamides for malignant melanoma.
    Liu X; Pham TQ; Berghofer P; Chapman J; Greguric I; Mitchell P; Mattner F; Loc'h C; Katsifis A
    Nucl Med Biol; 2008 Oct; 35(7):769-81. PubMed ID: 18848662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging malignant melanoma with (18)F-5-FPN.
    Feng H; Xia X; Li C; Song Y; Qin C; Liu Q; Zhang Y; Lan X
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):113-122. PubMed ID: 26260649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasensitive detection of malignant melanoma using PET molecular imaging probes.
    Pyo A; Kim DY; Kim H; Lim D; Kwon SY; Kang SR; Kim HS; Bom HS; Min JJ
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12991-12999. PubMed ID: 32439710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiopharmaceutical therapy of patients with metastasized melanoma with the melanin-binding benzamide 131I-BA52.
    Mier W; Kratochwil C; Hassel JC; Giesel FL; Beijer B; Babich JW; Friebe M; Eisenhut M; Enk A; Haberkorn U
    J Nucl Med; 2014 Jan; 55(1):9-14. PubMed ID: 24277756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo efficacy of melanoma internal radionuclide therapy with a 131I-labelled melanin-targeting heteroarylcarboxamide molecule.
    Degoul F; Borel M; Jacquemot N; Besse S; Communal Y; Mishellany F; Papon J; Penault-Llorca F; Donnarieix D; Doly M; Maigne L; Miot-Noirault E; Cayre A; Cluzel J; Moins N; Chezal JM; Bonnet M
    Int J Cancer; 2013 Sep; 133(5):1042-53. PubMed ID: 23404099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
    Koppe MJ; Bleichrodt RP; Soede AC; Verhofstad AA; Goldenberg DM; Oyen WJ; Boerman OC
    J Nucl Med; 2004 Jul; 45(7):1224-32. PubMed ID: 15235070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective local control of malignant melanoma by intratumoural injection of a beta-emitting radionuclide.
    Lee JD; Yang WI; Lee MG; Ryu YH; Park JH; Shin KH; Kim GE; Suh CO; Seong JS; Han BH; Choi CW; Kim EH; Kim KH; Park KB
    Eur J Nucl Med Mol Imaging; 2002 Feb; 29(2):221-30. PubMed ID: 11926384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [¹²³I]ICF01012 melanoma imaging and [¹³¹I]ICF01012 dosimetry allow adapted internal targeted radiotherapy in preclinical melanoma models.
    Viallard C; Perrot Y; Boudhraa Z; Jouberton E; Miot-Noirault E; Bonnet M; Besse S; Mishellany F; Cayre A; Maigne L; Rbah-Vidal L; D'Incan M; Cachin F; Chezal JM; Degoul F
    Eur J Dermatol; 2015; 25(1):29-35. PubMed ID: 25548082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of a 188Re-labeled alpha-melanocyte-stimulating hormone peptide analog in murine and human melanoma-bearing mouse models.
    Miao Y; Owen NK; Fisher DR; Hoffman TJ; Quinn TP
    J Nucl Med; 2005 Jan; 46(1):121-9. PubMed ID: 15632042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theranostics of malignant melanoma with 64CuCl2.
    Qin C; Liu H; Chen K; Hu X; Ma X; Lan X; Zhang Y; Cheng Z
    J Nucl Med; 2014 May; 55(5):812-7. PubMed ID: 24627435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-melanoma efficacy of internal radionuclide therapy in relation to melanin target distribution.
    Bonnet M; Mishellany F; Papon J; Cayre A; Penault-Llorca F; Madelmont JC; Miot-Noirault E; Chezal JM; Moins N
    Pigment Cell Melanoma Res; 2010 Oct; 23(5):e1-11. PubMed ID: 20444199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.